These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. The characteristics of hypoactive sexual desire disorder in Korean women who visited a community-based gynaecology hospital for sexual dysfunction. Yun HJ, Cho HH. J Obstet Gynaecol; 2018 Jul; 38(5):663-667. PubMed ID: 29433404 [Abstract] [Full Text] [Related]
27. Androgens and Psychosocial Factors Related to Sexual Dysfunctions in Premenopausal Women∗: ∗2016 ISSM Female Sexual Dysfunction Prize. Wåhlin-Jacobsen S, Kristensen E, Pedersen AT, Laessøe NC, Cohen AS, Hougaard DM, Lundqvist M, Giraldi A. J Sex Med; 2017 Mar; 14(3):366-379. PubMed ID: 28117267 [Abstract] [Full Text] [Related]
29. The presentation of hypoactive sexual desire disorder in premenopausal women. Maserejian NN, Shifren JL, Parish SJ, Braunstein GD, Gerstenberger EP, Rosen RC. J Sex Med; 2010 Oct; 7(10):3439-48. PubMed ID: 20646184 [Abstract] [Full Text] [Related]
30. Partner responses to low desire among couples coping with male hypoactive sexual desire disorder and associations with sexual well-being. Belu CF, Corsini-Munt S, Dubé JP, Wang GA, Rosen NO. J Sex Med; 2023 Jun 28; 20(7):955-964. PubMed ID: 37280187 [Abstract] [Full Text] [Related]
33. Sexual desire, distress, and associated factors in premenopausal women: preliminary findings from the hypoactive sexual desire disorder registry for women. Connor MK, Maserejian NN, De Rogatis L, Meston CM, Gerstenberger EP, Rosen RC. J Sex Marital Ther; 2011 Jun 28; 37(3):176-89. PubMed ID: 21512938 [Abstract] [Full Text] [Related]
34. A Systematic Literature Review of Health-related Quality of Life Measures for Women with Hypoactive Sexual Desire Disorder and Female Sexual Interest/Arousal Disorder. Lim-Watson MZ, Hays RD, Kingsberg S, Kallich JD, Murimi-Worstell IB. Sex Med Rev; 2022 Jan 28; 10(1):23-41. PubMed ID: 34481749 [Abstract] [Full Text] [Related]
35. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. West SL, D'Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Arch Intern Med; 2008 Jul 14; 168(13):1441-9. PubMed ID: 18625925 [Abstract] [Full Text] [Related]
36. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women. Pyke RE, Clayton AH. J Sex Med; 2019 Dec 14; 16(12):1885-1894. PubMed ID: 31678098 [Abstract] [Full Text] [Related]
37. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide. Althof S, Derogatis LR, Greenberg S, Clayton AH, Jordan R, Lucas J, Spana C. J Sex Med; 2019 Aug 14; 16(8):1226-1235. PubMed ID: 31277966 [Abstract] [Full Text] [Related]
38. Continued efficacy and safety of flibanserin in premenopausal women with Hypoactive Sexual Desire Disorder (HSDD): results from a randomized withdrawal trial. Goldfischer ER, Breaux J, Katz M, Kaufman J, Smith WB, Kimura T, Sand M, Pyke R. J Sex Med; 2011 Nov 14; 8(11):3160-72. PubMed ID: 21933348 [Abstract] [Full Text] [Related]
39. Sexual complaints, pelvic floor symptoms, and sexual distress in women over forty. Knoepp LR, Shippey SH, Chen CC, Cundiff GW, Derogatis LR, Handa VL. J Sex Med; 2010 Nov 14; 7(11):3675-82. PubMed ID: 20704643 [Abstract] [Full Text] [Related]
40. Assessment of Sexual Desire for Clinical Trials of Women With Hypoactive Sexual Desire Disorder: Measures, Desire-Related Behavior, and Assessment of Clinical Significance. Pyke RE, Clayton AH. Sex Med Rev; 2018 Jul 14; 6(3):367-383. PubMed ID: 29371145 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]